Bewacyzumab (Q1572885): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en, pl, and other parts: Updating entity Bewacyzumab with Lapacz) |
(Changed an Item: Updating statements of entity ["Bewacyzumab" (pl)] with Lapacz) |
||
Property / Version | |||
Property / Version: Leo Bonhart / rank | |||
Property / National Library Identifier | |||
a1000001126252 | |||
Property / National Library Identifier: a1000001126252 / rank | |||
Normal rank | |||
Property / Related Subject | |||
Property / Related Subject: Leki przeciwnowotworowe / rank | |||
Normal rank | |||
Property / Related Subject | |||
Property / Related Subject: Przeciwciała monoklonalne / rank | |||
Normal rank | |||
Property / Type | |||
Property / Type: Unknown / rank | |||
Normal rank | |||
Property / Version | |||
P46678T93039 | |||
Property / Version: P46678T93039 / rank | |||
Normal rank |
Latest revision as of 03:28, 25 December 2023
No description defined
- Bewacizumab
Language | Label | Description | Also known as |
---|---|---|---|
English | Bewacyzumab |
No description defined |
|
Statements
a1000001126252
0 references
P46678T93039
0 references